More InSilico Medicine Cayman TopCo news
InSilico Medicine Cayman TopCoHKEX: 3696

Voluntary announcement on-market share repurchase

Oct 29, 2026 at 8:15 PM EDT · Issued by InSilico Medicine Cayman TopCo via HKEXnews

Filed with HKEX · Stock code 3696 · Oct 29, 2026 at 8:15 PM EDT

On 6ix: 6ix.com/news/voluntary-announcement-on-market-share-repurchase-2

View Attachment

6ix is reading this filing.

View original source (HKEXnews)InSilico Medicine Cayman TopCo on 6ix

Earlier from InSilico Medicine Cayman TopCo

  • Grant of restricted share unitsOct 29
  • Voluntary announcement InSilico Medicine reports preliminary positive first-in-human clinical trial data for ISM6331 designed using generative AI in mesothelioma and other solid tumors at esmo 2026Oct 26
  • Voluntary announcement InSilico Medicine triggers a milestone payment in AI-driven R&D collaboration with servier for achieving early drug discovery milestoneOct 19
  • Voluntary announcement InSilico Medicine nominates peripheral-restricted VAV1 molecular glue degrader for potential treatment of autoimmune diseasesOct 12
  • Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026Oct 7
All InSilico Medicine Cayman TopCo news releases↗

Follow InSilico Medicine Cayman TopCo into a list and get an email when it puts out news.

Follow InSilico Medicine Cayman TopCo
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer